Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals, Inc. (ACXP) is a publicly traded company in the Unknown sector. Across all available filings, 3 corporate insiders have executed 13 transactions totaling $374.6K, demonstrating a bullish sentiment with $374.6K in net insider flow. The most recent transaction on Jan 19, 2024 involved a transaction of 19,737 shares valued at $70.1K.
ACXP Insider Activity Summary
Who Is Buying ACXP Stock?
No significant insider buying has been recorded for ACXP in the recent period.
Who Is Selling ACXP Stock?
No significant insider selling has been recorded for ACXP in the recent period.
Is Acurx Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ACXP is bullish with an Insider Alignment Score of 100/100 and a net flow of $374.6K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
ACXP Frequently Asked Questions
Understanding ACXP Insider Activity
Insider trading at Acurx Pharmaceuticals, Inc. (ACXP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 3 insiders are actively trading ACXP stock, having executed 13 transactions in the past 90 days. The most active insider is Carl Sailer (Executive), who has made 4 transactions totaling $245.0K.
Related Tools
Track Acurx Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at ACXP file new Form 4 transactions